Last reviewed · How we verify
Quadrivalent Influenza Standard Dose Vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Quadrivalent Influenza Standard Dose Vaccine (Quadrivalent Influenza Standard Dose Vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Quadrivalent Influenza Standard Dose Vaccine TARGET | Quadrivalent Influenza Standard Dose Vaccine | Sanofi Pasteur, a Sanofi Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Quadrivalent Influenza Standard Dose Vaccine CI watch — RSS
- Quadrivalent Influenza Standard Dose Vaccine CI watch — Atom
- Quadrivalent Influenza Standard Dose Vaccine CI watch — JSON
- Quadrivalent Influenza Standard Dose Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Quadrivalent Influenza Standard Dose Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/quadrivalent-influenza-standard-dose-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab